Ultime prove

EudraCT Number: 2018-003199-10

Sponsor Protocol Number: OLE-NLRC4/XIAP.2016.001

Start Date:

Sponsor Name: AB2 Bio Ltd.

Full Title: Open-label extension study with Tadekinig alfa (r-hIL-18BP) to monitor safety and tolerability in patients with IL-18 driven monogenic autoinflammatory conditions: NLRC4 mutation and XIAP deficiency

Medical condition: NLRC4 mutation XIAP deficiency

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: DE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2012-000856-33

Sponsor Protocol Number: 2012-40

Start Date:

Sponsor Name: Institut Pasteur

Full Title: A phase I/II, open-label, study of intracerebral administration of adeno-associated viral vector containing the human alpha-N-acetylglucosaminidase cDNA in children with Sanfilippo type B syndrome

Medical condition: Mucopolysaccharidosis III B

Disease:	Version	SOC Term	Classification Code	Term	Level
	17.0	10010331 - Congenital, familial and genetic disorders	10056890	Mucopolysaccharidosis III	PT

Population Age: Infants and toddlers, Children, Under 18

Gender: Male, Female

Trial protocol: FR (Completed)

Trial results: View results

EudraCT Number: 2010-021474-11

Sponsor Protocol Number: GE-001-013

Start Date:

Sponsor Name: GE Healthcare Ltd. and its Affiliates

Full Title: A Multicentre, Randomised, Open-label, Comparative Phase IV Trial To Assess Changes in Dementia Diagnostic Category and Diagnostic Confidence After DaTSCAN Imaging in Subjects with an Uncertain Dia...

Medical condition: Subjects with possible Dementia with Lewy Bodies (DLB) who may or may not also fulfil the criteria for Alzheimers Disease (AD)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) ES (Ongoing) IT (Completed)

Trial results: View results

EudraCT Number: 2004-001653-28

Sponsor Protocol Number: 03/314

Start Date:

Sponsor Name: The Leeds teaching Hospitals NHS trust

Full Title: A comparison of the effects on prostaglandin synthesis and cytokine production of an olive-oil based lipid emulsion (Clinoloeic) with a soya based emulsion (Intralipid) in newborn infnats receiving...

Medical condition: Prematurity Parenteral nutrition

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Preterm newborn infants, Newborns, Under 18

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2009-009278-29

Sponsor Protocol Number: S51477

Start Date:

Sponsor Name: UZ Leuven

Full Title: Follow-up studie: Metformin therapie bij kinderen en adolescenten met neurogene of neuromusculaire aandoeningen

Medical condition: Neuromuscular and neurological diseases, associated with obesity and insulin resistance

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10022489	Insulin resistance	LLT
	9.1		10022489	Insulin resistance	PT
	9.1		10029883	Obesity	LLT
	9.1		10065941	Central obesity	PT

Population Age: Adolescents, Under 18

Gender: Male, Female

Trial protocol: BE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2009-013956-62

Sponsor Protocol Number: DEMIJO

Start Date:

Sponsor Name: University Medical Center of the University Ulm

Full Title: Preparation of Neuroplant® 300mg N in film-coated tablets (St. John´s wort, SJW) in the treatment of mild to moderate Major Depressive Disorder (MDD) in adolescents from 12 to 17 years (inclusive):...

Medical condition: Mild to moderate MDD acc. DSM-IV-TR in adolescents (12−17years inclusive)

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.0		10025453	Major depressive disorder NOS	LLT

Population Age: Adolescents, Under 18

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2009-013499-29

Sponsor Protocol Number: SUNDRO20

Start Date:

Sponsor Name: Technische Universität München

Full Title: Dosisfindungsstudie für Sugammadex und Neostigmin zur Reversierung einer geringen neuromuskulären Restblockade (train of four ratio 0,2) [Sugammadex and Neostigmine dose finding study for reversal ...

Medical condition: Dose finding study for sugammadex and/or neostigmine at residual neuromuscular blockade (whereas residual neuromuscular blockade is defined as a TOF of 0.2 in this study).

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10057286	Neuromuscular blockade reversal	LLT
	9.1		10057286	Neuromuscular blockade reversal	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2013-001145-14

Sponsor Protocol Number: 2012.779

Start Date:

Sponsor Name: Hospices Civils de Lyon

Full Title: Traitement endoscopique de l’œsophage hypercontractile par injection de toxine botulinique : étude prospective, randomisée, contrôlée en double aveugle

Medical condition: Œsophage hypercontractile

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.0	100000004856	10065279	Nutcracker oesophagus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2019-002161-36

Sponsor Protocol Number: OP-108

Start Date:

Sponsor Name: Oncopeptides AB

Full Title: A Randomized, Controlled, Open-Label Phase 3 Study of Melflufen in combination with Daratumumab Compared with Daratumumab in Patients with Relapsed or Relapsed-Refractory Multiple Myeloma

Medical condition: Patients with relapsed or relapsed-refractory multiple myeloma.

Disease:	Version	SOC Term	Classification Code	Term	Level
	16.1	100000004851	10028229	Multiple myelomas	HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Prematurely Ended) NO (Completed) HU (Completed) FI (Completed) SK (Prematurely Ended) BG (Prematurely Ended) PL (Prematurely Ended) GR (Prematurely Ended) ES (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2011-005029-31

Sponsor Protocol Number: P110102

Start Date:

Sponsor Name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)

Full Title:

Medical condition:

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10038738 - Respiratory, thoracic and mediastinal disorders	10038683	Respiratory disorder	PT

Population Age: Children, Under 18

Gender:

Trial protocol: FR (Completed)

Trial results: (No results available)

Ultime prove

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici